LITTLE KNOWN FACTS ABOUT RAS-IN-2.

Participant has experienced almost every other prior or concurrent malignancy in two a long time previous to enrollment with the subsequent exceptions: sufficiently dealt with localized basal cell or squamous cell carcinoma, or curatively taken care of in situ carcinoma with the cervix or breast. Other exceptions might be deemed on sponsor session.